Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shen qu xiao shi oral liquid
- Development stage
- Phase 4
- Lead developer
- Yangtze River Pharmaceutical Group
- Administration
- Oral
01
Overview
Shen Qu Xiao Shi oral liquid is a traditional Chinese medicine (TCM) formulation primarily indicated for the treatment of functional dyspepsia, particularly in pediatric populations. The preparation is designed to promote digestion and harmonize the stomach, addressing symptoms such as abdominal distension, early satiety, and loss of appetite. Its primary component is Shen Qu (Massa Medicata Fermentata), a fermented herbal mixture known in TCM for resolving food stagnation. The drug has been evaluated in Phase 4 multicenter, randomized, double-blind, placebo-controlled clinical trials in China (e.g., ChiCTR-IPR-16009584) to assess its efficacy in symptom relief and its potential impact on the physical growth of children with chronic digestive issues.
- Brand names
- Shen Qu Xiao Shi oral liquid
- Other names
- Shenqu Xiaoshi Oral Liquid
02
Targets
STAT3 (Signal Transducer and Activator of Transcription 3)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)
Beyond the preview
Go deeper on shen qu xiao shi oral liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shen qu xiao shi oral liquid.